Spasticity is a disorder of muscle tone in which resistance to passive stretching increases as the speed of stretch increases. It results from damage to motor pathways in the central nervous system and is a component of the upper motor neuron syndrome. Spasticity commonly occurs after stroke, brain or spinal cord injury, and in several neurological diseases. Its effects range from a detectable change on examination to substantial interference with movement, comfort, positioning, and personal care.
Definition and terminology
In its classical neurological definition, spasticity is a velocity-dependent increase in the stretch reflex, accompanied by exaggerated tendon reflexes. When an examiner moves an affected joint slowly, resistance may be relatively slight; faster movement can produce a sudden “catch” or greater resistance.
The term is also used more broadly in clinical practice to describe involuntary muscle overactivity following central nervous system injury. This broader usage may include spasms and sustained abnormal postures, although these are not identical to spasticity in the strict sense.
Several related findings require distinction:
- Hypertonia is increased resistance to passive movement, regardless of its cause. Spasticity is one form of hypertonia.
- Spasms are involuntary muscle contractions that may occur spontaneously or in response to stimulation.
- Clonus is a series of rhythmic, involuntary contractions, often elicited by sustained muscle stretch.
- Contracture is a relatively fixed loss of joint movement caused by shortening or structural changes in muscles and other soft tissues. It can coexist with spasticity but is not itself a stretch-reflex abnormality.
- Dystonia involves sustained or intermittent contractions producing abnormal, often repetitive movements or postures.
Spasticity is therefore not a synonym for all muscle stiffness, and it does not encompass every consequence of an upper motor neuron lesion.
Mechanisms
Normally, descending pathways from the brain regulate spinal circuits that control muscle activity. A muscle’s response to stretch depends on the interaction of sensory input from muscle spindles, spinal interneurons, motor neurons, and descending control.
Damage to these pathways alters the balance of excitation and inhibition in the spinal cord. Changes in reflex regulation and motor-neuron excitability can make muscle responses to stretch excessive. The mechanisms are more complex than the loss of a single inhibitory pathway and can differ according to the location, extent, and duration of the lesion.
Over time, reduced movement and persistent abnormal muscle activity may also change the mechanical properties of muscle and connective tissue. Consequently, resistance felt during examination can contain both:
- A neural component, including stretch-evoked muscle contraction.
- A non-neural component, including tissue stiffness and shortening.
This distinction matters because treatments that reduce neural activity do not necessarily reverse established structural changes.
Causes and distribution
Spasticity occurs in conditions affecting central motor pathways. Common causes include stroke, multiple sclerosis, cerebral palsy, traumatic brain injury, and spinal cord injury. It can also occur in hereditary spastic paraplegias and other disorders affecting the brain or spinal cord.
The distribution often reflects the underlying lesion. It may predominantly affect one side of the body, both legs, or all four limbs. In an affected upper limb, patterns may include elbow, wrist, and finger flexion; in the lower limb, hip adduction or a downward-pointing foot may occur. These patterns are not universal and may reflect several forms of muscle overactivity together with weakness and soft-tissue changes.
Spasticity may evolve after the initial neurological injury rather than appearing immediately. Its severity can fluctuate with movement, body position, emotional stress, and sensory stimulation. Pain, bladder or bowel problems, skin injury, and infection can increase muscle overactivity without necessarily indicating progression of the original neurological disease.
Clinical effects
Spasticity often occurs alongside weakness, impaired selective movement, altered sensation, and reduced coordination. These accompanying deficits can be more important determinants of disability than increased muscle tone itself.
Possible consequences include difficulty walking, reduced hand use, disturbed sleep, painful spasms, and difficulty with dressing, hygiene, seating, or transfers. Persistent muscle overactivity and limited movement can contribute to contractures and abnormal joint positioning.
Its functional effects are not uniformly harmful. Some people use increased extensor tone to support standing or transfers despite substantial weakness. Reducing that tone may expose underlying weakness and worsen a particular activity. A decrease in measured tone therefore does not automatically represent improved function or health-related quality of life.
Assessment
Assessment combines medical history, neurological examination, and evaluation of daily activities. Examination considers the speed-dependent response to passive movement, tendon reflexes, clonus, voluntary strength, joint range, pain, and the distribution of abnormal muscle activity.
Two commonly used clinical measures are:
- Modified Ashworth Scale: grades resistance during passive movement. It is widely used but does not reliably separate reflex-mediated activity from mechanical stiffness.
- Tardieu Scale and its modifications: assess muscle responses at different stretch speeds and record joint angles, helping distinguish a dynamic catch from restricted passive range.
Neither scale fully captures the effect on everyday life. Assessment may also include walking, hand function, ease of care, spasm frequency, sleep, and individually defined goals. Instrumented methods can combine measurements of joint movement, force, and muscle electrical activity.
Spasticity is primarily a clinical finding. Magnetic resonance imaging and other investigations may identify its underlying cause, but do not independently establish its severity or functional significance.
Management
Management is generally part of multidisciplinary rehabilitation. Its targets may include comfort, mobility, positioning, prevention of secondary complications, or ease of care rather than normalization of muscle tone alone.
Physical and functional approaches
Physical therapy and occupational therapy may involve positioning, active movement, task practice, stretching, and adaptations to daily activities. Orthoses and serial casting are used in selected circumstances to influence alignment or maintain range of movement. Effects vary by intervention and condition; stretching alone has limited evidence for producing clinically important, lasting improvements in joint mobility.
Medicines and focal procedures
Oral medicines such as baclofen and tizanidine reduce muscle overactivity in some patients. Their use can be limited by adverse effects, including sedation, weakness, or low blood pressure, depending on the medicine.
Botulinum toxin injections reduce activity in selected muscles by temporarily inhibiting neurotransmitter release at the neuromuscular junction. They can improve focal muscle overactivity and some care-related outcomes, although improvement in active function is variable. Local weakness and, rarely, effects beyond the injection site can occur.
Intrathecal baclofen delivers medication into the cerebrospinal fluid through an implanted pump and is used in selected cases of severe spasticity. Pump or catheter failure can interrupt delivery; abrupt withdrawal and overdose are potentially serious complications.
Surgery
Selected procedures include tendon lengthening or other orthopedic operations for established deformity, and selective dorsal rhizotomy, which reduces sensory input contributing to spinal reflex activity. These procedures address different components of the problem and have distinct risks and functional consequences.
Interpretation of outcomes
Treatment studies use diverse outcomes, including muscle-tone scores, passive range, pain, walking performance, care burden, and participation. Improvement in one domain does not establish improvement in another. Differences in underlying disease, coexisting weakness, contracture, and treatment goals also limit direct comparison between studies.